CRYOGENIC SOLUTIONS CYGS Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRYOGENIC SOLUTIONS CYGS

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steven Angelil who wrote (3)	8/17/1997 12:30:00 PM
From: lloyd bashaw	of 19

May 19, 1997--Cryogenic Solutions Inc. (OTC: CYGS) announced Monday the company's successful acquisition of use rights to a vector which expresses sequence specific single-stranded DNA (ssDNA) in live eukaryotes (everything except plants and bacteria). Within nine months the company (CSI) will complete the construction of a "vector cassette" which will express sequent specific ssDNA in vivo. CSI believes a market will develop for its vector cassette among the array of biomedical investigators interested in the telomere of various organisms, including humans. Telomeres are the redundant ends of the chromosomes and current literature indicates the telomere can be manipulated to overcome or induce cell senescence (death). Telomeres have also been linked to changes in geriatric genetic expression. "Our ssDNA vector cassette is a bioengineered alternative to expressing telomerase. Telomerase is the focus of extensive research by several biotechs. Hopefully, we can help them move on to the next step," said company president Dell Gibson. CSI has arranged sufficient financing to complete the ssDNA expression vector cassette. The company is negotiating with various parties regarding licensing the technology for commercial food production and animal research with a view toward human application. The company's ssDNA vector cassette can be targeted to effect selected tissues according to the customer's application. More information is available on the web at texserve.com . CONTACT: Cryogenic Solutions Inc., Houston Dell Gibson, 713/780-1399

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next